Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

If your post was specifically directed at me then please allow me to explain my definition of what I view as transparency.

First of all, my first email to the Company (Michael Frank) was on October 1, 2020. Per the Company’s August 19, 2020 Press Release they were planning to expand the clinical trials to the Asia-Pacific countries and Canada. My email simply inquired if plans were still in place for the Company to expand the trials to these areas. Disappointedly, i received no response and i personally viewed his non-response as simply wanting to avoid answering “no” to my question, since to this day the Company still has not expanded the trials to these areas.

Per the Company’s Press Release on December 23, 2020 it was stated that they were on pace for the interim analysis on the first 210 patients. Between January 25, 2021 to January 28, 2021 I sent the Company (Michael Frank) 5 emails, simply looking for actual clarification that the 210 patients threshold had been achieved. I also inquired that if the threshold had been achieved if the DSMB were in the process of reviewing the data. My view was that these were simple questions that could be answered which would not be construed as the Company providing insider knowledge. My first 4 emails received no response until i sent a revised 5th email.

Michael Frank’s response…
((“It’s a Phase 3 double blinded study
Do you understand what that is ?

As you see on clinicaltrials.gov the study is progressing well and progressing

Thank you for your support
That’s all that can be said now”))

I understand that the clinical trial is a double blinded study. I understand that the Company can’t give me a response as to how the trial is proceeding, data wise (good or bad). I wasn’t inquiring about that. The transparency I was alluding to was simply for the Company to give a better, actual clarification on something that, imo, they had vaguely commented on. Michael Frank’s response, imo, did not provide that transparency.

Let me just say that I believe in the science of Bucillamine. I hope my email on February 9, 2021 had some impact which eventually persuaded the Company to put out today’s Press Release. I like this transparency.

On a lighter note, wondering how long this Pr will keep the tantrum throwers satisfied before they resurface to vent about ""transparency"". LOL